Position in ABOS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$358,078
+$146,703 QoQ
Shares Held
151,728
+51.5% QoQ
Ownership
0.210%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 84 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 64.3111357165454.ToString("F0")%
Shared 0.ToString("F0")%
None 35.6888642834546.ToString("F0")%
Common Shares in ABOS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,293,122,197 across 420 Biotechnology names. ABOS ranks #315 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in ABOS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $358,078 | 151,728 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $211,375 | 100,178 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $182,419 | 106,678 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $123,746 | 106,678 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $573,326 | 521,206 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $904,386 | 525,806 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,280,686 | 516,406 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,056,487 | 436,565 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $331,200 | 81,778 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $326,699 | 85,078 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $248,078 | 59,778 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $287,532 | 59,778 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $242,698 | 59,778 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $322,801 | 59,778 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $475,201 | 47,378 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $162,046 | 34,478 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $722,794 | 184,858 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $752,813 | 111,363 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,482,656 | 99,775 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||